API reference

Brimonidine tartrate

CAS number
70359-46-5
Molecular formula
C15H16BrN5O6
Molecular weight
442.22 g/mol
Brimonidine tartrate — 2D structure
2D structure (PubChem)

About this molecule

Brimonidine Tartrate is the tartrate salt form of brimonidine, an imidazole derivative and a selective alpha-2 adrenergic receptor agonist. Upon ocular administration, brimonidine tartrate acts on the blood vessels causing them to constrict which leads to a decrease in the production of aqueous humor. Brimonidine tartrate also enhances the outflow of aqueous humor. This drug is used in the treatment of glaucoma to reduce intraocular pressure.

Source: NCI Thesaurus (NCIt), via PubChem.

Identifiers

IUPAC name
5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine;(2R,3R)-2,3-dihydroxybutanedioic acid
InChIKey
QZHBYNSSDLTCRG-LREBCSMRSA-N
SMILES
C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O
Other CAS numbers recorded
79570-19-7 · 109826-56-4
PubChem CID
54405

Also known as

BRIMONIDINE TARTRATE · Alphagan · Qoliana · Lumify · Bromoxidine tartrate · Brominide tartrate · mirvaso · OCU300

Chemical data on this page is drawn from PubChem (National Library of Medicine) and is provided for identification only. Hanpars does not hold stock of every substance listed; availability, grade, documentation and regulatory status are confirmed per enquiry.

Tell us the grade, the quantity and the market.

Send the molecule or ingredient, the specification and the destination. We reply from Tehran with the questions, the documents and the next step.

Telephone+98 21 8888 3325 · office hours 09:00–17:00, Tehran
OfficeHaniya Parsan Darou, 3rd floor, No. 326, Zafar Street, Africa Boulevard, Tehran 1968734974, Iran
Emailcontact@hanpars.com